Avidity Biosciences (RNA) Research & Development: 2019-2025
Historic Research & Development for Avidity Biosciences (RNA) over the last 7 years, with Sep 2025 value amounting to $154.9 million.
- Avidity Biosciences' Research & Development rose 100.72% to $154.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.2 million, marking a year-over-year increase of 87.20%. This contributed to the annual value of $303.6 million for FY2024, which is 58.98% up from last year.
- Avidity Biosciences' Research & Development amounted to $154.9 million in Q3 2025, which was up 12.18% from $138.1 million recorded in Q2 2025.
- In the past 5 years, Avidity Biosciences' Research & Development ranged from a high of $154.9 million in Q3 2025 and a low of $20.7 million during Q1 2021.
- For the 3-year period, Avidity Biosciences' Research & Development averaged around $80.6 million, with its median value being $66.8 million (2024).
- Data for Avidity Biosciences' Research & Development shows a peak YoY spiked of 272.96% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Avidity Biosciences' Research & Development stood at $33.0 million in 2021, then soared by 38.35% to $45.6 million in 2022, then rose by 15.80% to $52.8 million in 2023, then surged by 81.05% to $95.6 million in 2024, then spiked by 100.72% to $154.9 million in 2025.
- Its Research & Development was $154.9 million in Q3 2025, compared to $138.1 million in Q2 2025 and $99.5 million in Q1 2025.